Treatment with baloxavir marboxil significantly reduced the risk of onward transmission of influenza within households.

In terms of how quickly they alleviate symptoms, oseltamivir and baloxavir are on par, said Yen. But baloxavir is better at ...

Health authorities have said that stockpiled Tamiflu should work well against H5N1. Some experts question that bet.

It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...

Results from a late-stage study on RHHBY's Xofluza show that the drug reduces the transmission of influenza from an infected ...

Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses: Basel Friday, September 20, 2024, 09:00 Hrs [IST] Roche announc ...

Roche's phase 3 CENTERSTONE study shows Xofluza (baloxavir marboxil) significantly reduces influenza transmission in ...

Roche has achieved a research success with its flu drug Xofluza. As the latest data from the pivotal Centerstone study show, Xofluza has reduced the transmission of influenza from an infected person ...

Roche today released positive top-line results of the Phase III CENTERSTONE study of Xofluza (baloxavir marboxil), an ...

According to the company, the results are the first time an antiviral drug has reduced transmission of a respiratory virus in ...

Roche (RHHBF) unit Genentech said Xofluza antiviral reached the main goal in a global Phase 3 trial, reducting the ...

Roche has achieved a research success with its influenza drug Xofluza. As the latest data from the pivotal Centerstone study show, Xofluza has reduced the transmission of influenza from an infected ...